SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+1.05%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$249M
AUM Growth
+$249M
(-25%)
Cap. Flow
-$78.1M
Cap. Flow
% of AUM
-31.36%
Top 10 Holdings %
Top 10 Hldgs %
61.55%
Holding
64
New
7
Increased
31
Reduced
6
Closed
11
Top Buys
| 1 |
Centene
CNC
|
$14.2M |
| 2 |
Disc Medicine
IRON
|
$11.2M |
| 3 |
Sanofi
SNY
|
$9.06M |
| 4 |
Edgewise Therapeutics
EWTX
|
$7.08M |
| 5 |
Maximus
MMS
|
$5.6M |
Top Sells
| 1 |
Icon
ICLR
|
$35.6M |
| 2 |
Zimmer Biomet
ZBH
|
$21.2M |
| 3 |
Labcorp
LH
|
$19.5M |
| 4 |
Teleflex
TFX
|
$14.9M |
| 5 |
Neurocrine Biosciences
NBIX
|
$10.9M |
Sector Composition
| 1 | Healthcare | 83.62% |
| 2 | Industrials | 15.44% |
| 3 | Technology | 0.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Maximus
MMS
$4.95B
| $38.5M | 14.69% | 548,086 +79,734 | +17% | +$5.6M |
|
|
2
Disc Medicine
IRON
$2.07B
| $15.1M | 5.76% | 284,787 +211,276 | +287% | +$11.2M |
|
3
Globus Medical
GMED
$8.27B
| $14.5M | 5.54% | 245,570 +38,570 | +19% | +$2.28M |
|
|
4
Centene
CNC
$14.3B
| $14.2M | 5.44% | +262,500 | New | +$14.2M |
|
5
Merck
MRK
$210B
| $13.8M | 5.26% | 173,951 -96,645 | -36% | -$7.65M |
|
|
DRUG
6
Bright Minds Biosciences
DRUG
$276M
| $13.4M | 5.11% | 512,338 +4,776 | +0.9% | +$125K |
|
|
7
Neurocrine Biosciences
NBIX
$13.8B
| $12.7M | 4.84% | 100,725 -86,848 | -46% | -$10.9M |
|
8
BioMarin Pharmaceuticals
BMRN
$11.2B
| $12.4M | 4.73% | 225,114 +83,980 | +60% | +$4.62M |
|
9
Annexon
ANNX
$226M
| $9.83M | 3.75% | 4,095,764 +697,978 | +21% | +$1.68M |
|
|
10
Sanofi
SNY
$121B
| $9.06M | 3.46% | +187,500 | New | +$9.06M |
|
11
Tyra Biosciences
TYRA
$675M
| $7.75M | 2.96% | 810,274 +393,657 | +94% | +$3.77M |
|
12
ANI Pharmaceuticals
ANIP
$2.03B
| $7.37M | 2.81% | 112,923 +25,625 | +29% | +$1.67M |
|
|
13
Edgewise Therapeutics
EWTX
$1.51B
| $7.08M | 2.7% | +539,730 | New | +$7.08M |
|
|
AVR
14
Anteris Technologies Global Corp. Common Stock
AVR
$145M
| $6.97M | 2.66% | 1,839,022 -530,938 | -22% | -$2.01M |
|
|
SEPN
15
Septerna, Inc. Common Stock
SEPN
$539M
| $6.18M | 2.36% | 584,435 -204,235 | -26% | -$2.16M |
|
16
Artivion
AORT
$2.07B
| $4.94M | 1.89% | 158,736 +37,558 | +31% | +$1.17M |
|
17
Dianthus Therapeutics
DNTH
$759M
| $4.4M | 1.68% | 236,070 +119,073 | +102% | +$2.22M |
|
18
ProQR Therapeutics
PRQR
$237M
| $4.23M | 1.62% | 2,075,139 +20,546 | +1% | +$41.9K |
|
19
PMV Pharmaceuticals
PMVP
$74.2M
| $3.96M | 1.51% | 3,735,396 | – | – |
|
20
Avanos Medical
AVNS
$554M
| $3.54M | 1.35% | 288,849 +2,860 | +1% | +$35K |
|
21
Merus
MRUS
$4.98B
| $3.3M | 1.26% | +62,719 | New | +$3.3M |
|
22
Aquestive Therapeutics
AQST
$456M
| $3.14M | 1.2% | 947,489 +555,860 | +142% | +$1.84M |
|
23
Ventyx Biosciences
VTYX
$171M
| $2.8M | 1.07% | 1,307,964 -1,274,691 | -49% | -$2.73M |
|
|
MBX
24
MBX Biosciences, Inc. Common Stock
MBX
$507M
| $2.75M | 1.05% | +241,000 | New | +$2.75M |
|
25
IDEAYA Biosciences
IDYA
$2.15B
| $2.61M | 1% | 124,230 +1,230 | +1% | +$25.9K |
|